Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Indegene Limited has informed the Exchange regarding a press release dated January 09, 2025, titled "CliniOps Announces Strategic Partnership with Indegene to Accelerate Clinical Trials". | Download
Indegene Limited has informed the Exchange regarding a press release dated January 09, 2025, titled "CliniOps Announces Strategic Partnership with Indegene to Accelerate Clinical Trials". | Download
Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant